Ecteinascidin 770
Ecteinascidin 770 is a small molecule that inhibits RNA-dependent RNA polymerase 1 (RDRP1), demonstrating antiviral activity against SARS-CoV-2 and antibacterial effects against Mycobacterium tuberculosis in vitro. Its primary research application is in oncology for studying cancer cell viability mechanisms.
Product Specifications
CAS Number
114899-80-8
Product Name Alternative
Ecteinascidin 770, Ecteinascidine 770, Et770, Et-770, U373MG cell
Field of Research
Cell Biology, Infectious Disease & Virology, Molecular Biology
Purity
99.84% (May vary between batches)
Solubility
DMSO:40 mg/mL (51.89 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (2.59 mM)
Smiles
C (#N) [C@@H]1N2[C@@] ([C@]3 (C=4C ([C@@]2 (COC (=O) [C@@]5 (CS3) C=6C (=CC (O) =C (OC) C6) CCN5) [H]) =C7C (=C (C) C4OC (C) =O) OCO7) [H]) ([C@]8 (C=9C (C[C@@]1 (N8C) [H]) =CC (C) =C (OC) C9O) [H]) [H]
Molecular Formula
C40H42N4O10S
Molecular Weight
770.85
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR10313379 96 Well
Mouse 3 ketodihydrosphingosine reductase (KDSR) ELISA Kit
Sign In for Pricing
View Details 
MBS1353012-01 0.5 mg (E-Coli)
Recombinant Xenopus laevis Leucine-rich repeat-containing protein 59 (lrrc59), partial
Sign In for Pricing
View Details MBS1353012-02 0.05 mg (Baculovirus)
Recombinant Xenopus laevis Leucine-rich repeat-containing protein 59 (lrrc59), partial
Sign In for Pricing
View Details 
MBS1353012-03 0.5 mg (Yeast)
Recombinant Xenopus laevis Leucine-rich repeat-containing protein 59 (lrrc59), partial
Sign In for Pricing
View Details MBS1353012-04 0.05 mg (Mammalian-Cell)
Recombinant Xenopus laevis Leucine-rich repeat-containing protein 59 (lrrc59), partial
Sign In for Pricing
View Details MBS1353012-05 1 mg (E-Coli)
Recombinant Xenopus laevis Leucine-rich repeat-containing protein 59 (lrrc59), partial
Sign In for Pricing
View Details